Cathie Wood Chooses Medical AI Over Mark Zuckerberg: Ark Loads Up On TEM Stock, Dumps Meta Shares

The Tempus AI TradeThis purchase aligns with Tempus’ recent collaboration with Daiichi Sankyo, aiming to enhance AI-driven biomarker discovery in oncology. The collaboration seeks to leverage AI models for patient selection, potentially boosting the success rate of new treatments. The total value of the shares bought by Ark Invest in Tempus AI is approximately $3.97 million.The Meta Platforms TradeThe Archer Aviation TradeArk Invest’s ARKK fund sold 463,363 shares of Archer Aviation Inc (NYSE:ACHR) , with t ...